GlobalData on MSN11h
MindMed doses first subject in Phase III Panorama study of GAD tablet
Mind Medicine (MindMed) has dosed the first subject in the Phase III Panorama study of a proprietary form of lysergide ...
Optimistic Buy Rating for Mind Medicine’s MM120 Amid Promising Phase 3 Progress and Strong Phase 2b Results
Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Mind Medicine (MNMD – Research Report). The associated price ...
H.C. Wainwright Sticks to Their Buy Rating for Mind Medicine (MNMD)
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Mind Medicine (MNMD – Research Report) today and set a price target of ...